Cyclerion Therapeutics, Inc. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cyclerion Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2023.
  • Cyclerion Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $0.000, a 100% decline year-over-year.
  • Cyclerion Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $5.02M, a 82.7% decline from 2022.
  • Cyclerion Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $29M, a 5.8% decline from 2021.
  • Cyclerion Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $30.8M, a 9.59% increase from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $5.02M -$24M -82.7% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $29M -$1.79M -5.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $30.8M +$2.7M +9.59% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $28.1M -$183M -86.7% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-24
2019 $212M +$111M +110% Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 $101M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.